{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:43:30Z","timestamp":1792806210681,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012159","name":"Myelin Repair Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012159","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["T32HS000063"],"award-info":[{"award-number":["T32HS000063"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["K12TR004381"],"award-info":[{"award-number":["K12TR004381"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["K23EY036499"],"award-info":[{"award-number":["K23EY036499"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001209","name":"Knights Templar Eye Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001209","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006396","name":"Alexion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021057","name":"Luminopia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007745","name":"Massachusetts Lions Eye Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007745","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006823","name":"Boston Children's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ophtha.2025.12.027","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T04:48:08Z","timestamp":1770785288000},"page":"680-689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Visual Outcomes of Plasma Exchange for Acute Optic Neuritis"],"prefix":"10.1016","volume":"133","author":[{"given":"John J.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isdin","family":"Oke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J.","family":"Dinkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mays A.","family":"El-Dairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Gaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aubrey L.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"MacIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather E.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy L.","family":"Pineles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gena","family":"Heidary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2025.12.027_bib1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajo.2020.07.014","article-title":"Population-based incidence of optic neuritis in the era of aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies","volume":"220","author":"Hassan","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.027_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1474-4422(22)00187-9","article-title":"Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment","volume":"22","author":"Bennett","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ophtha.2025.12.027_bib3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group","volume":"326","author":"Beck","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2025.12.027_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.survophthal.2019.08.001","article-title":"Optic neuritis in the era of biomarkers","volume":"65","author":"Chen","year":"2020","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.027_bib5","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S1474-4422(22)00200-9","article-title":"Diagnosis and classification of optic neuritis","volume":"21","author":"Petzold","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ophtha.2025.12.027_bib6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamaophthalmol.2017.6757","article-title":"Prevalence of myelin oligodendrocyte glycoprotein and aquaporin-4-IgG in patients in the Optic Neuritis Treatment Trial","volume":"136","author":"Chen","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.027_bib7","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.ophtha.2024.03.020","article-title":"Trends in plasma exchange use in optic neuritis hospitalizations in the United States","volume":"131","author":"Akosman","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.12.027_bib8","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/bjh.12629","article-title":"The mechanisms of action of plasma exchange","volume":"164","author":"Reeves","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ophtha.2025.12.027_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/1756286420947977","article-title":"Vision improvement in severe acute isolated optic neuritis after plasma exchange treatment in Chinese population: a prospective case series study","volume":"13","author":"Tan","year":"2020","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.ophtha.2025.12.027_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jca.22043","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2014evidence-based approach from the Writing Committee of the American Society for Apheresis: the ninth special issue","volume":"38","author":"Connelly-Smith","year":"2023","journal-title":"J Clin Apher"},{"key":"10.1016\/j.ophtha.2025.12.027_bib11","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/jnnp-2017-316286","article-title":"Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders","volume":"89","author":"Bonnan","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ophtha.2025.12.027_bib12","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q","article-title":"A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease","volume":"46","author":"Weinshenker","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ophtha.2025.12.027_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1472-6963-11-101","article-title":"Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barre syndrome","volume":"11","author":"Winters","year":"2011","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.ophtha.2025.12.027_bib14","first-page":"344","article-title":"Cost analysis of treatment with therapeutic plasma exchange versus treatment with intravenous immunoglobulins in patients with immune-based neurological diseases. Proposal for optimising the use of plasmatic blood products","volume":"40","author":"Antelo","year":"2025","journal-title":"Neurologia (Engl Ed)"},{"key":"10.1016\/j.ophtha.2025.12.027_bib15","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1186\/s12913-022-08210-z","article-title":"Cost-minimisation analysis of plasma exchange versus IVIg in the treatment of autoimmune neurological conditions","volume":"22","author":"Klemencic Kozul","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.ophtha.2025.12.027_bib16","series-title":"The Oxford 2011 Levels of Evidence","year":"2014"},{"key":"10.1016\/j.ophtha.2025.12.027_bib17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ajo.2023.02.013","article-title":"Visual outcomes following plasma exchange for optic neuritis: an international multicenter retrospective analysis of 395 optic neuritis attacks","volume":"252","author":"Chen","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.027_bib18","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/archophthalmol.2012.1126","article-title":"Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica","volume":"130","author":"Merle","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.027_bib19","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00415-016-8073-8","article-title":"Plasma exchange response in 34 patients with severe optic neuritis","volume":"263","author":"Deschamps","year":"2016","journal-title":"J Neurol"},{"key":"10.1016\/j.ophtha.2025.12.027_bib20","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s40120-022-00344-w","article-title":"Efficacy of plasma exchange treatment for demyelinating optic neuritis associated with various serum antibodies: a prospective cohort study","volume":"11","author":"Fu","year":"2022","journal-title":"Neurol Ther"},{"key":"10.1016\/j.ophtha.2025.12.027_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104020","article-title":"Treatment outcomes of first-ever episode of severe optic neuritis","volume":"66","author":"Galetta","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.ophtha.2025.12.027_bib22","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/1744-9987.13844","article-title":"Therapeutic plasma exchange for optic neuritis attacks in patients with neuromyelitis optica spectrum disorders","volume":"26","author":"Gonzalez","year":"2022","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.ophtha.2025.12.027_bib23","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10384-018-0602-9","article-title":"Short-term effect of additional apheresis on visual acuity changes in patients with steroid-resistant optic neuritis in neuromyelitis optica spectrum disorders","volume":"62","author":"Mori","year":"2018","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.027_bib24","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1212\/01.WNL.0000138437.99046.6B","article-title":"Plasma exchange for severe optic neuritis: treatment of 10 patients","volume":"63","author":"Ruprecht","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ophtha.2025.12.027_bib25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1159\/000504027","article-title":"Visual outcomes of plasma exchange treatment of steroid-refractory optic neuritis: a retrospective monocentric analysis","volume":"46","author":"Skorupka","year":"2019","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.ophtha.2025.12.027_bib26","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1007\/s10792-019-01090-z","article-title":"Plasma exchange: an effective add-on treatment of optic neuritis in neuromyelitis optica spectrum disorders","volume":"39","author":"Song","year":"2019","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.027_bib27","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/archopht.1988.01060140207023","article-title":"The optic neuritis treatment trial","volume":"106","author":"Beck","year":"1988","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.12.027_bib28","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0140-6736(66)92025-3","article-title":"Treatment of acute retrobulbar neuritis with corticotrophin","volume":"2","author":"Rawson","year":"1966","journal-title":"Lancet"},{"key":"10.1016\/j.ophtha.2025.12.027_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0161-6420(88)33220-3","article-title":"Treatment of optic neuritis with intravenous megadose corticosteroids. A consecutive series","volume":"95","author":"Spoor","year":"1988","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642025008139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642025008139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:11:32Z","timestamp":1792804292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642025008139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0161642025008139"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2025.12.027","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Visual Outcomes of Plasma Exchange for Acute Optic Neuritis","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2025.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}